AACR Annual Meeting 2026

April 17–22, 2026 · San Diego · 2418 items

Over 22,000 attendees and more than 7,400 abstracts, including a record 265 clinical trial abstracts. This section collects on-site analysis across fifteen signal directions, plus late-breaking, clinical-trial and new-drug abstracts.

Apr 22Wed

Wednesday · 30 items

21:33
x.com@Score6060
We’re pleased to share updates from Sutro Biopharma at the American Association for Cancer Research (@AACR) Annual Meeting 2026.
Same topic #SUTROBIO · 2 peopleHeat 11 like0 replies0 reposts
21:30
x.com@Score6060
We presented preclinical data highlighting an innovative new class of mutant-targeted catalytic RAS(ON) inhibitors at the @AACR Annual Me...
Heat 2623 likes1 reply2 reposts
21:29
x.com@Score6060
PD-L1 looks like a negative biomarker (pCR in AEGEAN in PD-L1 neg was 9%) and CD39 seems independent
Heat 33 likes0 replies0 reposts
21:19
x.com@Score6060
#AACR26 We presented our Double Lung Transplant for Cancer updates from @NorthwesternMed.
CT257Heat 1511 likes1 reply3 reposts
21:18
x.com@Score6060
7/ Spearheaded by @LisaCSchweizer (@OmicVision) and @jiminmin_v from @Aiims1742 group (@Perlmutter_CC), with Michael Hollingsworth and ...
Same topic #PANCREATICCANCER · 11 people #DEEPVISUALPROTEOMICSHeat 65 likes0 replies1 repost
21:18
x.com@Score6060
Out now in @CD_AACR, timed with my #AACR26 talk.
Same topic KRAS · 51 peopleHeat 116 likes1 reply4 reposts
21:16
x.com@Score6060
Dr. Lauren Averett Byers delivered an optimistic presentation at #AACR26 about the advances made for small cell lung cancer treatment.
Heat 1917 likes1 reply1 repost
21:12
x.com@Score6060
Coming up today at #AACR26 radiopharmaceutical expert Dr Ravi Patel (@RPatelMDPHD ) talks about the development of radioligand & emer...
Heat 118 likes0 replies3 reposts
21:05
x.com@Score6060
New commentary highlights exciting new work on AI detection of bone metastasis on routine CT https://t.co/BCJHDqcW3X @AACR #AACR26 #AACR2...
Same topic #ONCORAD · 3 peopleHeat 11 like0 replies0 reposts
21:00
x.com@Score6060
Join Pfizer Oncology Medical at #AACR26! Visit our poster presentation to learn about an early investigation of a bispecific antibody the...
Heat 31 like0 replies2 reposts
20:56
x.com@Score6060
The IO neoadjuvant approach continues to be impressive in resectable NSCLC. Kudos to @barlesi for leading this study and for the great #A...
Heat 1914 likes1 reply4 reposts
20:38
x.com@Score6060
Last Chance to stop by booth 3922 to sign up and learn more about #ScienceWebinars series! #AACR26
Same topic #SCIENCEWEBINARS · 2 peopleHeat 21 like0 replies1 repost
20:36
x.com@Score6060
Don't forget to register the post-#AACR26 session from the COALA network (https://t.co/jYptkghBdH), where I will summarize the promising ...
#LUNG #LCSMHeat 10 likes0 replies1 repost
20:30
x.com@Score6060
Last day of #AACR26, and don't miss @CarrotJian's presentation.
Heat 146 likes0 replies8 reposts
20:29
x.com@Score6060
🔥🔥Presented at #AACR26 by Dr Lyudmila Bazhenova @UCSDCancer impressive Duration of response for 1L
taletrectenib ROS1 #TALETRECTENIB #TRUST-I #LCSMHeat 5839 likes2 replies17 reposts
20:27
x.com@Score6060
Drug development is supposed to be linear.
Same topic daraxonrasib · 63 people RM-055Heat 209166 likes2 replies41 reposts
20:26
x.com@Score6060
What a pleasure to talk with Ziren Kong and Jiangang Zhang about their exciting work! #AACR26 @CCR_AACR https://t.co/rfpJlOgqrR
Heat 53 likes0 replies2 reposts
20:25
x.com@Score6060
#AACR26 A very thoughtful discussion on perioperative immunotherapy and adenosine in particular, noting the need to design robust sample ...
Heat 86 likes0 replies2 reposts
20:25
x.com@Score6060
#AACR26 How does it fare vs other adenosine studies? Oleclumab (anti-CD73) was studied in NeoCOAST-2 and showed pCR 20.3% (16% in PDL1 ne...
oleclumabHeat 54 likes1 reply0 reposts
20:25
x.com@Score6060
#AACR26 The adenosine pathway is an appealing target given its immunosuppressive role. IPH5201 targets CD39 and has in vitro synergy with...
Same topic durvalumab · 8 peopleHeat 1110 likes1 reply0 reposts
20:25
x.com@Score6060
#AACR26 In MATISSE, need to acknowledge the heterogeneity and going forward, should we distinguish N2 vs non-N2? pCR rates of IPH5201 + d...
Heat 32 likes1 reply0 reposts
20:25
x.com@Score6060
Dr. Tina Cascone with an insightful discussion on the MATISSE trial at #AACR26 plenary session. Outlines the current state of neoadjuvant...
Heat 10876 likes4 replies28 reposts
20:20
x.com@Score6060
Congratulations to Ziren Kong on his simultaneous publication in @CCR_AACR at #AACR26! Editor-in-Chief Timothy Yap stopping by the poster...
Heat 11 like0 replies0 reposts
20:16
x.com@Score6060
We shared preclinical data on our CCNE1-directed MGD at #AACR26, highlighting a potential first-in-class approach to a frequently amplifi...
Same topic MRT-55811 · 2 peopleHeat 54 likes0 replies1 repost
20:12
x.com@Score6060
Data from the phase 2 MATISSE trial from @barlesi at #AACR26: perioperative IPH5201 (CD39 inhibitor) + durvalumab + neoadjuvant chemother...
Same topic durvalumab · 8 peopleHeat 5640 likes4 replies12 reposts
20:12
x.com@Score6060
#AACR26 Safety signals as expected: asthenia, arthralgias, hypothyroidism. Radiographic RR 62.5%. 87.5% of patients underwent resection (...
Heat 1812 likes0 replies6 reposts
19:56
x.com@Score6060
We’ve partnered with tertiary analysis platforms, Genomize, Geneyx, & Golden Helix to enhance our hereditary cancer panel. Combining ...
Heat 1110 likes0 replies1 repost
19:18
x.com@Score6060
Abstract CT011: Genomic HER2 amplification predicts for complete clinical response in a phase II study of induction tucatinib and trastuz...
CT011 tucatinib trastuzumab HER2Heat 2817 likes0 replies11 reposts
19:09
x.com@Score6060
Good morning San Diego!
Heat 2317 likes0 replies6 reposts
19:04
x.com@Score6060
.@AACR_CEO Margaret Foti shared the inaugural recipients of the Trailblazer Cancer Research Grants Program during the #AACR26 Opening Cer...
Heat 1611 likes0 replies5 reposts